The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

Non-animal testing methods could save drugmakers time and money, officials say ...

The U.S. Food and Drug Administration issued a draft guidance on Wednesday to help drug developers validate alternative methods that can be used in place of animal studies during early stages of drug ...

Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...

The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...

New draft guidance from the FDA is urging pharma companies to accelerate efforts to transition from animal testing to ...

March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...

HHS has made reducing animal testing a priority over the past year. In April 2025, the FDA announced it would phase out the animal testing requirement for monoclonal antibodies. A few months later, ...

Last November, the UK government announced a bold plan to phase out animal testing in some areas of research. Animal tests for skin irritation are scheduled for elimination this year, and some studies ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

Animal studies often fail to predict human tissue responses to new drugs or newly developed therapies. Besides generating ...